1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2022Efficacy and safety of GX-188E, a therapeutic DNA vaccine, combined with pembrolizumab in HPV 16- and/or 18- positive advanced cervical cancer (phase II): Safe and effective in both PD-L1 positive and negativeANNALS OF ONCOLOGY
2022Dynamic changes of peripheral regulatory t cells during parp inhibitor maintenance therapy in patients with ovarian cancerINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Durvalumab, in combination with and following chemoradiotherapy, in locally advanced cervical cancer: results from the phase 3 international, randomized, double-blind, placebo-controlled calla trialINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Comprehensive profiling of cervix cancer patients using tumor next-generation sequencing (NGS) and immunohistochemistry (IHC)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Clinical relevance of red blood cell distribution as prognostic marker in endometrial carcinomaINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Clinical outcomes of BRCA1/2 pathogenic variants in ovarian cancer cluster region in patients with primary peritoneal, epithelial ovarian, and fallopian tube cancerGYNECOLOGIC ONCOLOGY
2022An open label, single arm, multicenter trial of durvalumab and BVAC-C, in patients with HPV 16 or 18 positive recurrent cervical cancer INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Added value of sentinel lymph node biopsy in patients with negative lymph node on triple pre-operative imagesINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022A double-blind, 4-block randomized, placebo-controlled, adaptive phase 2/3 trial to confirm efficacy of BLS-ILB-E710c in patients with cervical intraepithelial neoplasia 2/3 with extension study INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2023Chromosomal Abnormality, fetal/neonatal Death and Socioeconomic Status: A Prospective Cohort StudyMaternal and Child Health Journal
2023High ATP6V1B1 expression is associated with poor prognosis and platinum-based chemotherapy resistance in epithelial ovarian cancerOncology Reports
2023Differential Expression of NME4 in Trophoblast Stem-Like Cells and Peripheral Blood Mononuclear Cells of Normal Pregnancy and PreeclampsiaJournal of Korean Medical Science
2023HOXA-AS3 induces tumor progression through the epithelial-mesenchymal transition pathway in epithelial ovarian cancerOncology Reports
2023Clinical Relevance of Uterine Manipulation on Oncologic Outcome in Robot-Assisted versus Open Surgery in the Management of Endometrial CancerJOURNAL OF CLINICAL MEDICINE
2022Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse OutcomesCLINICAL CANCER RESEARCH
2022A Phase 2 study of prexasertib (LY2606368) in platinum resistant or refractory recurrent ovarian cancerGynecologic Oncology
2022Sentinel lymph node biopsy in high-risk endometrial cancer: performance, outcomes, and future avenuesObstetrics & Gynecology Science
2023High-Dose Selenium Induces Ferroptotic Cell Death in Ovarian CancerInternational Journal of Molecular Sciences
2023Ovarian Real-World International Consortium (ORWIC): A multicentre, real-world analysis of epithelial ovarian cancer treatment and outcomesFrontiers in Oncology
2023Cost-Effectiveness Analysis of Germline and Somatic BRCA Testing in Patients With Advanced Ovarian CancerAnnals of Laboratory Medicine

Recent Submissions

Browse

Links